BDBrigitta Dombai
Brigitta Dombai
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Brigitta Dombai has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Andras Bikov
Manchester Academic Health Science Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK
1 shared publication Anikó Bohács
Department of Pulmonology, Semmelweis University, Budapest, Hungary
1 shared publicationBarna Vásárhelyi
Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary
1 shared publicationDóra Oroszi
Department of Pulmonology, Semmelweis University, Budapest, Hungary
1 shared publicationGyörgy Losonczy
Department of Pulmonology, Semmelweis University, Budapest, Hungary
1 shared publication- István Ivancsó
Klinik für Anästhesie, Kantonsspital Aarau, Aarau, Switzerland
1 shared publication
Latest Publications
- Open Access
- 1 January 2017
- Published by Wiley in Canadian Respiratory Journal
- Vol. 2017, 1-8
Circulating Clusterin and Osteopontin Levels in Asthma and Asthmatic Pregnancy
Asthma in pregnancy poses a risk of adverse outcomes. Osteopontin and clusterin emerged as asthma biomarkers; however, their circulating levels during pregnancy are unknown yet. This cross-sectional study investigated peripheral osteopontin and clusterin levels and their relationship to disease control in 26 asthmatic pregnant (AP), 22 asthmatic nonpregnant (ANP), and 25 healthy pregnant (HP) women and 12 healthy controls (HNP). Osteopontin levels of ANP and HNP were similar (2.142versus 2.075 ng/mL,). Pregnancy caused a marked elevation in both healthy (HP: 3.037 ng/ml,versus HNP) and asthmatic (AP: 2.693 ng/ml) patients; thus the pregnant groups did not differ (). Circulating clusterin levels were comparable in ANP and HNP (109.2versus 108.8 µg/mL,) and the level was lower in HP (98.80 µg/mL,versus HNP). In contrast, the level was higher in AP (111.7 µg/mL,versus HP). In ANP, a positive correlation of PEF (;) and a negative correlation of(;) to clusterin level were detected. Circulating osteopontin level increases in pregnancy regardless of concomitant well-controlled asthma, indicating its gestational role. Clusterin level decreases in healthy but not in asthmatic pregnancy and correlates directly with lung function.- 1 January 2017
- Published by Wiley in Canadian Respiratory Journal
- Vol. 2017, 1-8
Open AccessCirculating Clusterin and Osteopontin Levels in Asthma and Asthmatic Pregnancy
Asthma in pregnancy poses a risk of adverse outcomes. Osteopontin and clusterin emerged as asthma biomarkers; however, their circulating levels during pregnancy are unknown yet. This cross-sectional study investigated peripheral osteopontin and clusterin levels and their relationship to disease control in 26 asthmatic pregnant (AP), 22 asthmatic nonpregnant (ANP), and 25 healthy pregnant (HP) women and 12 healthy controls (HNP). Osteopontin levels of ANP and HNP were similar (2.142versus 2.075 ng/mL,). Pregnancy caused a marked elevation in both healthy (HP: 3.037 ng/ml,versus HNP) and asthmatic (AP: 2.693 ng/ml) patients; thus the pregnant groups did not differ (). Circulating clusterin levels were comparable in ANP and HNP (109.2versus 108.8 µg/mL,) and the level was lower in HP (98.80 µg/mL,versus HNP). In contrast, the level was higher in AP (111.7 µg/mL,versus HP). In ANP, a positive correlation of PEF (;) and a negative correlation of(;) to clusterin level were detected. Circulating osteopontin level increases in pregnancy regardless of concomitant well-controlled asthma, indicating its gestational role. Clusterin level decreases in healthy but not in asthmatic pregnancy and correlates directly with lung function.